back to cluster viewer
cluster path 0101110110111
144 words, 11,397 tokens
freq alpha suffix
Words in frequency order
1 | deaths | 8,016
|
2 | withdrawals | 947
|
3 | dropouts | 601
|
4 | discontinuations | 582
|
5 | mortalities | 296
|
6 | drop-outs | 234
|
7 | fatalities | 189
|
8 | bed-days | 40
|
9 | false-positives | 33
|
10 | seroconversions | 32
|
11 | refusals | 29
|
12 | reinfarctions | 28
|
13 | re-infections | 24
|
14 | enrollments | 23
|
15 | cardioversions | 22
|
16 | cancellations | 16
|
17 | completions | 12
|
18 | strandings | 10
|
19 | epizootics | 8
|
20 | retransplantations | 8
|
21 | deaths/year | 7
|
22 | lcnvas | 7
|
23 | symptom-days | 7
|
24 | syncopes | 7
|
25 | enrolees | 6
|
26 | euro/year | 6
|
27 | rapes | 6
|
28 | sartan | 6
|
29 | enrolments | 5
|
30 | gens | 5
|
31 | absentees | 4
|
32 | admissions/year | 4
|
33 | cm_128 | 4
|
34 | neuroprostheses | 4
|
35 | relocations | 4
|
36 | rhcs | 4
|
37 | tuberculomas | 4
|
38 | turps | 4
|
39 | zilpaterol-hcl | 4
|
40 | angiologists | 3
|
41 | aβ1-16 | 3
|
42 | candidemias | 3
|
43 | dhatus | 3
|
44 | lrrs | 3
|
45 | non-entries | 3
|
46 | over-mortality | 3
|
47 | pelzneria | 3
|
48 | quadriplegics | 3
|
49 | remindings | 3
|
50 | seclusions | 3
|
51 | ad-6048 | 2
|
52 | allosucking | 2
|
53 | ardfp+mega-art | 2
|
54 | ardfp+standard-art | 2
|
55 | beta-endorphins | 2
|
56 | cath-labs | 2
|
57 | common.h2ras | 2
|
58 | death.we | 2
|
59 | defectors | 2
|
60 | discomfort/complications | 2
|
61 | haemoparasites | 2
|
62 | hospital-days | 2
|
63 | hypertrygliceridaemia | 2
|
64 | ige-sensitization | 2
|
65 | low-bonding | 2
|
66 | m··· | 2
|
67 | nil-by-mouth | 2
|
68 | outcome.2 | 2
|
69 | re-ruptures | 2
|
70 | s-alleles | 2
|
71 | surveillance.settings | 2
|
72 | ≥1× | 2
|
73 | -2-alkynols | 1
|
74 | 3000k | 1
|
75 | 7396 | 1
|
76 | action-memories | 1
|
77 | analphabet | 1
|
78 | atoravastin | 1
|
79 | bereavements | 1
|
80 | break-reunion | 1
|
81 | breast-milk-samples | 1
|
82 | brevistigma | 1
|
83 | bupropion-remitters | 1
|
84 | cases/month | 1
|
85 | creatase | 1
|
86 | da-pages | 1
|
87 | deaths-two | 1
|
88 | deep-bite | 1
|
89 | defunctions | 1
|
90 | dentals/alveolars | 1
|
91 | diarrhoea.children | 1
|
92 | dyhd | 1
|
93 | dysfunctionalies | 1
|
94 | eortc-oes-18 | 1
|
95 | epacs | 1
|
96 | f643 | 1
|
97 | fat-losses | 1
|
98 | flatfeet | 1
|
99 | fructification | 1
|
100 | gracilipes | 1
|
101 | h.e.l.p.-apherses | 1
|
102 | hla-mismatches | 1
|
103 | hours≥8 | 1
|
104 | ld-patients | 1
|
105 | leg/foot-ulcers | 1
|
106 | lesions-may | 1
|
107 | lives/year | 1
|
108 | lp1002165 | 1
|
109 | mges | 1
|
110 | morbidity-mainly | 1
|
111 | morbo-mortality | 1
|
112 | neo-anus | 1
|
113 | nonarousals | 1
|
114 | oral-nasal-facial | 1
|
115 | other-references | 1
|
116 | out-crossing | 1
|
117 | over-usage | 1
|
118 | pabpa | 1
|
119 | pads/liners | 1
|
120 | pregnancy/childbirth | 1
|
121 | pseudobacteraemia | 1
|
122 | pseudoneutropenia | 1
|
123 | pyelonephitis | 1
|
124 | re-amputations | 1
|
125 | re-explorations | 1
|
126 | re-thrombosis | 1
|
127 | rehemorrhages | 1
|
128 | remanipulations | 1
|
129 | remission=0.65 | 1
|
130 | remission=0.87 | 1
|
131 | rifaximin-resistance | 1
|
132 | rituximab-arm | 1
|
133 | serotonin-toxicity | 1
|
134 | snps-rs966513 | 1
|
135 | st1737 | 1
|
136 | suctions | 1
|
137 | survival-were | 1
|
138 | test-imprecision | 1
|
139 | tetrazane | 1
|
140 | tf/muc1 | 1
|
141 | toxicity- | 1
|
142 | trephined | 1
|
143 | tvi-e/a | 1
|
144 | ε-phase | 1
|
Words in alphabetical order
1 | -2-alkynols | 1
|
2 | 3000k | 1
|
3 | 7396 | 1
|
4 | absentees | 4
|
5 | action-memories | 1
|
6 | ad-6048 | 2
|
7 | admissions/year | 4
|
8 | allosucking | 2
|
9 | analphabet | 1
|
10 | angiologists | 3
|
11 | ardfp+mega-art | 2
|
12 | ardfp+standard-art | 2
|
13 | atoravastin | 1
|
14 | aβ1-16 | 3
|
15 | bed-days | 40
|
16 | bereavements | 1
|
17 | beta-endorphins | 2
|
18 | break-reunion | 1
|
19 | breast-milk-samples | 1
|
20 | brevistigma | 1
|
21 | bupropion-remitters | 1
|
22 | cancellations | 16
|
23 | candidemias | 3
|
24 | cardioversions | 22
|
25 | cases/month | 1
|
26 | cath-labs | 2
|
27 | cm_128 | 4
|
28 | common.h2ras | 2
|
29 | completions | 12
|
30 | creatase | 1
|
31 | da-pages | 1
|
32 | death.we | 2
|
33 | deaths | 8,016
|
34 | deaths-two | 1
|
35 | deaths/year | 7
|
36 | deep-bite | 1
|
37 | defectors | 2
|
38 | defunctions | 1
|
39 | dentals/alveolars | 1
|
40 | dhatus | 3
|
41 | diarrhoea.children | 1
|
42 | discomfort/complications | 2
|
43 | discontinuations | 582
|
44 | drop-outs | 234
|
45 | dropouts | 601
|
46 | dyhd | 1
|
47 | dysfunctionalies | 1
|
48 | enrolees | 6
|
49 | enrollments | 23
|
50 | enrolments | 5
|
51 | eortc-oes-18 | 1
|
52 | epacs | 1
|
53 | epizootics | 8
|
54 | euro/year | 6
|
55 | f643 | 1
|
56 | false-positives | 33
|
57 | fat-losses | 1
|
58 | fatalities | 189
|
59 | flatfeet | 1
|
60 | fructification | 1
|
61 | gens | 5
|
62 | gracilipes | 1
|
63 | h.e.l.p.-apherses | 1
|
64 | haemoparasites | 2
|
65 | hla-mismatches | 1
|
66 | hospital-days | 2
|
67 | hours≥8 | 1
|
68 | hypertrygliceridaemia | 2
|
69 | ige-sensitization | 2
|
70 | lcnvas | 7
|
71 | ld-patients | 1
|
72 | leg/foot-ulcers | 1
|
73 | lesions-may | 1
|
74 | lives/year | 1
|
75 | low-bonding | 2
|
76 | lp1002165 | 1
|
77 | lrrs | 3
|
78 | mges | 1
|
79 | morbidity-mainly | 1
|
80 | morbo-mortality | 1
|
81 | mortalities | 296
|
82 | m··· | 2
|
83 | neo-anus | 1
|
84 | neuroprostheses | 4
|
85 | nil-by-mouth | 2
|
86 | non-entries | 3
|
87 | nonarousals | 1
|
88 | oral-nasal-facial | 1
|
89 | other-references | 1
|
90 | out-crossing | 1
|
91 | outcome.2 | 2
|
92 | over-mortality | 3
|
93 | over-usage | 1
|
94 | pabpa | 1
|
95 | pads/liners | 1
|
96 | pelzneria | 3
|
97 | pregnancy/childbirth | 1
|
98 | pseudobacteraemia | 1
|
99 | pseudoneutropenia | 1
|
100 | pyelonephitis | 1
|
101 | quadriplegics | 3
|
102 | rapes | 6
|
103 | re-amputations | 1
|
104 | re-explorations | 1
|
105 | re-infections | 24
|
106 | re-ruptures | 2
|
107 | re-thrombosis | 1
|
108 | refusals | 29
|
109 | rehemorrhages | 1
|
110 | reinfarctions | 28
|
111 | relocations | 4
|
112 | remanipulations | 1
|
113 | remindings | 3
|
114 | remission=0.65 | 1
|
115 | remission=0.87 | 1
|
116 | retransplantations | 8
|
117 | rhcs | 4
|
118 | rifaximin-resistance | 1
|
119 | rituximab-arm | 1
|
120 | s-alleles | 2
|
121 | sartan | 6
|
122 | seclusions | 3
|
123 | seroconversions | 32
|
124 | serotonin-toxicity | 1
|
125 | snps-rs966513 | 1
|
126 | st1737 | 1
|
127 | strandings | 10
|
128 | suctions | 1
|
129 | surveillance.settings | 2
|
130 | survival-were | 1
|
131 | symptom-days | 7
|
132 | syncopes | 7
|
133 | test-imprecision | 1
|
134 | tetrazane | 1
|
135 | tf/muc1 | 1
|
136 | toxicity- | 1
|
137 | trephined | 1
|
138 | tuberculomas | 4
|
139 | turps | 4
|
140 | tvi-e/a | 1
|
141 | withdrawals | 947
|
142 | zilpaterol-hcl | 4
|
143 | ε-phase | 1
|
144 | ≥1× | 2
|
Words in suffix order
1 | toxicity- | 1
|
2 | tf/muc1 | 1
|
3 | outcome.2 | 2
|
4 | snps-rs966513 | 1
|
5 | f643 | 1
|
6 | remission=0.65 | 1
|
7 | lp1002165 | 1
|
8 | aβ1-16 | 3
|
9 | 7396 | 1
|
10 | st1737 | 1
|
11 | remission=0.87 | 1
|
12 | eortc-oes-18 | 1
|
13 | cm_128 | 4
|
14 | ad-6048 | 2
|
15 | hours≥8 | 1
|
16 | tvi-e/a | 1
|
17 | hypertrygliceridaemia | 2
|
18 | pseudobacteraemia | 1
|
19 | pseudoneutropenia | 1
|
20 | pelzneria | 3
|
21 | brevistigma | 1
|
22 | pabpa | 1
|
23 | trephined | 1
|
24 | dyhd | 1
|
25 | rifaximin-resistance | 1
|
26 | over-usage | 1
|
27 | tetrazane | 1
|
28 | survival-were | 1
|
29 | ε-phase | 1
|
30 | creatase | 1
|
31 | deep-bite | 1
|
32 | death.we | 2
|
33 | low-bonding | 2
|
34 | allosucking | 2
|
35 | out-crossing | 1
|
36 | cases/month | 1
|
37 | pregnancy/childbirth | 1
|
38 | nil-by-mouth | 2
|
39 | 3000k | 1
|
40 | oral-nasal-facial | 1
|
41 | zilpaterol-hcl | 4
|
42 | rituximab-arm | 1
|
43 | sartan | 6
|
44 | diarrhoea.children | 1
|
45 | atoravastin | 1
|
46 | break-reunion | 1
|
47 | test-imprecision | 1
|
48 | fructification | 1
|
49 | ige-sensitization | 2
|
50 | deaths-two | 1
|
51 | euro/year | 6
|
52 | lives/year | 1
|
53 | deaths/year | 7
|
54 | admissions/year | 4
|
55 | candidemias | 3
|
56 | tuberculomas | 4
|
57 | common.h2ras | 2
|
58 | lcnvas | 7
|
59 | cath-labs | 2
|
60 | epacs | 1
|
61 | rhcs | 4
|
62 | quadriplegics | 3
|
63 | epizootics | 8
|
64 | other-references | 1
|
65 | enrolees | 6
|
66 | absentees | 4
|
67 | rehemorrhages | 1
|
68 | da-pages | 1
|
69 | mges | 1
|
70 | hla-mismatches | 1
|
71 | dysfunctionalies | 1
|
72 | action-memories | 1
|
73 | non-entries | 3
|
74 | fatalities | 189
|
75 | mortalities | 296
|
76 | s-alleles | 2
|
77 | breast-milk-samples | 1
|
78 | rapes | 6
|
79 | gracilipes | 1
|
80 | syncopes | 7
|
81 | re-ruptures | 2
|
82 | neuroprostheses | 4
|
83 | h.e.l.p.-apherses | 1
|
84 | fat-losses | 1
|
85 | haemoparasites | 2
|
86 | false-positives | 33
|
87 | strandings | 10
|
88 | remindings | 3
|
89 | surveillance.settings | 2
|
90 | deaths | 8,016
|
91 | re-thrombosis | 1
|
92 | pyelonephitis | 1
|
93 | refusals | 29
|
94 | nonarousals | 1
|
95 | withdrawals | 947
|
96 | -2-alkynols | 1
|
97 | gens | 5
|
98 | beta-endorphins | 2
|
99 | seroconversions | 32
|
100 | cardioversions | 22
|
101 | seclusions | 3
|
102 | discomfort/complications | 2
|
103 | relocations | 4
|
104 | cancellations | 16
|
105 | remanipulations | 1
|
106 | re-explorations | 1
|
107 | retransplantations | 8
|
108 | re-amputations | 1
|
109 | discontinuations | 582
|
110 | re-infections | 24
|
111 | defunctions | 1
|
112 | reinfarctions | 28
|
113 | suctions | 1
|
114 | completions | 12
|
115 | turps | 4
|
116 | dentals/alveolars | 1
|
117 | leg/foot-ulcers | 1
|
118 | pads/liners | 1
|
119 | bupropion-remitters | 1
|
120 | defectors | 2
|
121 | lrrs | 3
|
122 | ld-patients | 1
|
123 | bereavements | 1
|
124 | enrollments | 23
|
125 | enrolments | 5
|
126 | angiologists | 3
|
127 | drop-outs | 234
|
128 | dropouts | 601
|
129 | neo-anus | 1
|
130 | dhatus | 3
|
131 | bed-days | 40
|
132 | hospital-days | 2
|
133 | symptom-days | 7
|
134 | analphabet | 1
|
135 | flatfeet | 1
|
136 | ardfp+mega-art | 2
|
137 | ardfp+standard-art | 2
|
138 | lesions-may | 1
|
139 | morbidity-mainly | 1
|
140 | serotonin-toxicity | 1
|
141 | morbo-mortality | 1
|
142 | over-mortality | 3
|
143 | ≥1× | 2
|
144 | m··· | 2
|